Latest Breaking News On - Cadila health - Page 4 : comparemela.com

(PTI Photo) New Delhi: Zydus Cadila has received emergency use approval from the Drugs Controller General of India (DGCI) for the use of Virafin in treating moderate Covid-19 infection in adults. A single-dose of the antiviral Virafin will make the treatment more convenient for the patients. When administered early on during COVID-19, Virafin will help patients recover faster and avoid much of the complications, the company said. In a release, Cadila Health highlighted that the drug has also shown efficacy against other viral infections. Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited, said, The fact that we are able to offer a therapy which significantly reduces the viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19.

New delhiZydus cadilaSharvil patelCadila healthCadila healthcareDrugs controller generalManaging directorCadila healthcare limitedபுதியது டெல்ஹிஜய்துச் காடிலாஷார்வில் படேல்காடிலா ஆரோக்கியம்காடிலா சுகாதாரம்மருந்துகள் கட்டுப்படுத்தி ஜநரல்நிர்வகித்தல் இயக்குனர்காடிலா சுகாதாரம் வரையறுக்கப்பட்டவை